Cancer kills more people in developing countries than HIV, tuberculosis and malaria combined. Most cancer patients (75%) in developing countries have advanced or incurable cancers at the time they present to the health system for diagnosis. Together with Axios International, the Axios Foundation is pioneering new approaches and partnering with leading pharmaceutical companies to improve access to drugs and treatment in developing countries and encourage positive changes in care-seeking behavior.
Click here to download fact sheet.
Improving Access to Cancer Drugs
Through partnerships with leading global pharmaceutical companies, Axios is bringing cancer treating drugs to patients in developing countries. Our supply chain and logistics network helps bring lifesaving drugs to patients throughout Africa, Asia and the Middle East. Using our on-the-ground knowledge, we are able to identify local partner institutions and physicians to provide drugs and treatment to eligible patients.
GARDASIL® Access Program
In partnership with Merck and in coordination with Axios International, the Axios Foundation is currently the implementing partner of the GARDASIL Access Program. The program has enabled organizations in 20 countries to gain operational experience designing and implementing HPV vaccination projects, with the goal of supporting the development of successful adolescent immunization model. Over one million doses have been shipped, benefitting over 300,000 girls in 20 developing countries.
Strengthening Breast Cancer Treatment
In Ethiopia, the Axios Foundation partnered with the Tikur Anbessa Hospital, with funding from AstraZeneca, in a unique initiative to address the limited diagnostic and treatment services for breast cancer. The project included the development of clinical guidelines for breast cancer treatment and palliative care, capacity building, patient management and follow-up systems, the installation of mammography and ultrasound equipment, and drug donations. Ethiopia’s Ministry of Health has since established a committee to develop cancer control policies in collaboration with staff from Tikur Anbessa Hospital.